Protein Hydrolysis Enzymes Market : Business Opportunities and Global Industry Analysis

According to a research report Protein Hydrolysis Enzymes Market by Source (Microorganisms, Animals, Plants), Method of Production (Fermentation and Extraction), Product, Application (Detergent, Pharmaceuticals, Food, Textiles & Leather) and Region – Global Forecast to 2027″ published by MarketsandMarkets, the protein hydrolysis enzymes market is projected to reach USD 2.9 billion by 2027, growing at a CAGR of 6.2% from 2022 to 2027.

The protein hydrolysis is also prominently used s in the detergent industry. They represent one of the major groups of enzymes and are characterized by their widespread use in detergents. In addition to raising the level of cleaning, protein also provide environmental benefits by reducing energy consumption through shorter washing times, lower washing temperatures, and reduced water consumption.

Global meat production and consumption have increased rapidly in recent decades. According to the OECD-FAO Agricultural Outlook the global meat supply is projected to increase to 374 Mt by 2030. The rise in global consumption demand of meat proteins in the coming decade is estimated to grow by 14% by 2030.

Owing to these reasons, new feed enzymes especially protein hydrolysis are rapidly adopted by the meat industry as they are used in feed industry for the purpose of animal nutrition; essential to meet the growing demand for meat. This has also facilitated the development of significant new technology to advance their use and availability. The importance of functionality is expected to be sustained for a long period of time due to lack of efficient substitutes to protein hydrolysis enzymes.

Download PDF Brochure:

Asia Pacific region is anticipated to witness the highest growth rate in the protein hydrolysis enzymes market during the forecast period.

In the Asia Pacific region, the protein hydrolysis enzymes market is largely driven by the increasing usage in detergents, pharmaceuticals, and food industries. The countries in the region such as China, India, Japan, and South Korea are highly reputed in the global pharmaceutical market for their continuous technological innovation. According to National Bureau of Statistics (NBS), China ranked second in the world in terms of research and development. Moreover, the research and development investment are expected to increase by 7% annually during 2021 to 2025. According to the April 2022 report of Indian Pharmaceuticals Industry Analysis, the Indian pharmaceutical market experienced a 13.9% growth in overall revenue in January 2022. The increase in technological innovations in the pharmaceutical segment coupled with growing research and development investments are anticipated to propel the growth of the market in the region.

The key players in this market include Novozymes (Denmark), Associated British Foods (UK), DSM (Netherlands), DuPont (US), BASF (Germany), Advanced Enzymes Technologies (India), and Chr. Hansen (Denmark).

The pharmaceuticals segment is identified to be the fastest-growing segment among the various applications of protein hydrolysis enzymes during the forecast period

Protein hydrolysis enzymes are used extensively for the preparation of medicines, such as ointments for debridement of wounds and used in denture cleaners. Protein hydrolysis enzymes from microbial sources are preferred over those from plant and animal sources due to their wide biochemical diversity and genetic susceptibility. Application of microbial protein hydrolysis enzymes in the pharmaceuticals industry such as serrapeptase, serrazime, lysostaphin, L-asparaginase, L-glutaminase, streptokinase, streptokinase-streptodornase, and xiaflex. These enzymes are used to treat cancer, cardiovascular disease, respiratory tract disorders, and inflammation. Application of plant protein hydrolysis enzymes in the pharmaceutical industry includes papain and bromelain. Papain is an effective enzyme used in treating dyspepsia and other digestive disorders. Papain is used to treat ringworm, remove warts, and heal skin injuries because of its capacity to break down dead tissue without harming living tissue. Bromelain is used in the treatment of cardiovascular disease, decrustation of burns and as an anti-inflammatory agent. Animal-based protein hydrolysis enzymes are applied in the pharmaceutical industry include pepsin, trypsin & chymotrypsin, hyaluronidase, urokinase and collagenase. Pepsin is mainly used to aid protein digestion. Trypsin can be used as a wet or dry dressing as well as an ointment. Hyaluronidase helps drug diffusion when conjugated with other drugs such as antibiotics, adrenalin, heparin, and local anesthesia. Urokinase and collagenase in blood clot removal and skin ulcers.

Speak to Analyst: